| Trial registration number
|
NCT04998708 |
Full text link
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04998708
|
First author
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
2021-08-10
|
Recruitment status
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- a recent mild or moderate covid-19 with no or low-grade fever 99.5- 100.94 °f
(37.5-38.3 °c)
|
Exclusion criteria
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
- any patient was not hospitalized and had high-grade fever <100.94 °f (<38.3 °c) or
other chronic diseases such as heart problems, hypertension, or diabetes. women how
were using contraceptives were excluded because contraceptives decrease immune
functions and might affect the subjectivity to autoimmune disorders with marked
increases in risk for various autoimmune disorders
|
Number of arms
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Beni-Suef University
|
Inclusion age min
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
25
|
Inclusion age max
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
45
|
Countries
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Turkey
|
Type of patients
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Mild/moderate disease at enrollment
|
Severity scale
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
2: Mild/moderate disease at enrollment
|
Total sample size
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
30
|
primary outcome
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
Immune biomarkers;Wisconsin Upper Respiratory Symptom Survey
|
Notes
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Aug. 11, 2021, 4 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 837, "treatment_name": "Muscle relaxation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|